Patents
Patents for C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
05/2008
05/14/2008EP1390023B1 Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds
05/14/2008CN100387600C N-substituted hydromorphones and the use thereof
05/07/2008EP1485051B1 Method of administering buprenorphine to treat depression
04/2008
04/30/2008CN101171253A Hydrocodone polymorphs
04/23/2008EP1913001A2 (r)-n-methylnaltrexone, processes for its synthesis and its pharmaceutical use
04/23/2008EP1476141B1 Tamper-resistant transdermal opioid delivery devices
04/09/2008CN100379741C Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
04/02/2008CN101155814A Crystals of morphinan derivative and process for producing the same
03/2008
03/27/2008WO2008036980A1 Transdermally deliverable buprenorphine prodrugs and abuse-resistant compositions thereof
03/27/2008US20080076789 Transdermally deliverable opioid prodrugs, abuse-resistant compositions and methods of using opioid prodrugs
03/27/2008CA2663515A1 Transdermally deliverable buprenorphine prodrugs and abuse-resistant compositions thereof
03/26/2008EP1439179B1 New oripavine derivatives and their uses as medicines
03/26/2008CN101151266A Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof
03/26/2008CN101151250A Processes for preparing morphinans and intermediates thereof
03/25/2008US7348430 Reacting an alcohol of a 4,5-epoxymorphinan compound with benzophenone and potassium tert-alkylate, adding dimethyl sulfate or acetic anhydride to produce hydrocodone and dihydrocodeinone enol acetate; the ketone undergoes instantaneous conversion to the corresponding enolate
03/19/2008EP1899351A1 Method for separation and purification of naltrexone by preparative chromatography
03/13/2008US20080064712 17-allyl-4,5 alpha -epoxy-3-methoxy-14 beta -(3-phenylpropyloxy)morphinan-6-one with various substituents in Position 3 show higher analgesic activity than their 14-hydroxy analogues; opioid antagonists
03/06/2008US20080058502 Method for preparing microparticles having a selected polymer molecular weight
03/05/2008EP1893616A2 A new synthetic route to 14-hydroxyl opiates through 1-halo-thebaine or analogs
03/05/2008CN101137658A Antipruritic agent for pruritus caused by multiple sclerosis
02/2008
02/21/2008WO2008022285A1 Preparation and utility of opioid analgesics
02/21/2008US20080045716 preparing a 6-oxo-14-hydroxy- Delta 7-morphinane comprising oxidizing a 6-methoxy-N-methyl- Delta 6, Delta 8-morphinane; useful in the preparation of opiate alkaloids; utilise such intermediates in the synthesis of morphinane compounds
02/21/2008US20080045715 Preparation of Opiate Analgesics by Reductive Alkylation
02/21/2008US20080045558 opiod and/or N-methylaspartic acid receptor modulators, used for the treatment and/or management of pain, neurodegenerative diseases, drug abuse and dependence, vision defects, or as muscle relaxants, antitussive and anxiolytic agents
02/21/2008CA2661302A1 Preparation and utility of opioid analgesics
02/20/2008EP1889848A1 6,7-unsaturated-7-carbamoyl substituted morphinan derivative
02/20/2008CN101125137A Pharmaceutical salts
02/13/2008CN100368414C Morphinan derivatives the quaternary ammonium salts thereof substituted in position 14, method for production and use thereof
02/06/2008CN101119728A Indolomorphinan derivative having carboxy in 6'-position
01/2008
01/30/2008CN101115757A Method for purifying noroxymorphone compounds
01/29/2008US7323565 Using complex catalyst containing transition metal and phosphine
01/29/2008CA2256336C Quinolinomorphinan derivative and medical use thereof
01/22/2008US7321038 Method for the catalytic production of hydrocodone and hydromorphone
01/22/2008US7320984 Administering 4,5 alpha -epoxy-6 beta -(3,4-dihydro-2H-benzo[1,4]thiazino)-3-methoxy-17-methyl-morphinan; for urinary frequency, therapeutic or prophylactic effect and of which side effects are improved
01/02/2008EP1873158A1 Crystals of morphinan derivative and process for producing the same
01/02/2008EP1871775A1 Hydromorphone polymorphs
01/02/2008EP1871774A1 Method for the catalytic production of hydrocodone, hydromorphone, and derivatives thereof
12/2007
12/26/2007EP1870413A1 Antipruritic agent for pruritus caused by multiple sclerosis
12/26/2007CN101092397A Structure modified compound of sinomenine, and prepartion method
12/20/2007US20070293676 Method for Separation and Purification of Hydrocodone by Preparative Chromatography
12/19/2007CN101090722A 镇痛剂 Analgesics
12/12/2007EP1864987A2 Methods for making 3-O protected morphinones and 3-O-protected morphinone dienol carboxylates
12/12/2007EP1687310B1 Method for the catalytic production of hydrocodone and hydromorphone
12/06/2007US20070281958 Preparation of oxycodone
12/06/2007US20070281957 Crystalline Forms of Levorphanol
12/05/2007EP1861406A2 Hydrocodone polymorphs
12/05/2007EP1861373A2 Processes for preparing morphinans and intermediates thereof
12/05/2007CN100352431C Pharmaceutical salts
11/2007
11/22/2007WO2007103105A3 Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
11/15/2007US20070265293 Opioid antagonists; lyophilization
11/07/2007EP1851226A1 Method for purifying noroxymorphone compounds
11/07/2007EP0915094B1 Morphinane derivatives and medicinal use thereof
11/01/2007WO2007124114A2 Stereoselective reduction of a morphinone
10/2007
10/31/2007CN101065384A Method for separation and purification of hydrocodone by preparative chromatography
10/25/2007US20070248667 Tannate Compositions and Methods of Use
10/25/2007DE202005021371U1 Oxycodonhydrochlorid mit weniger als 25 ppm 14-Hydroxycodeinon Oxycodone hydrochloride with less than 25 ppm 14-hydroxycodeinone
10/25/2007CA2649360A1 Mono and di-substituted oxycodone compounds and compositions
10/24/2007EP1562952B1 Method for the catalytic production of hydrocodone and hydromorphone
10/23/2007US7285665 Process for the preparation of quaternary N-alkyl morphinan alkaloid salts
10/18/2007US20070241065 Extraction of Alkaloids for Opium
10/17/2007EP1843768A2 Substituted morphinans and methods of their use
10/09/2007US7279579 Polymorphic forms of naltrexone
10/04/2007WO2007110637A1 Method for extracting target alkaloid using an ionic liquid as extracting solvent
10/03/2007EP1838714A1 Methods of treating pain
10/03/2007EP1838317A1 Analgesic conjugates
09/2007
09/26/2007EP1837396A1 Salutaridine reductase and morphine biosynthesis
09/26/2007EP1837022A1 Indolomorphinan derivative having carboxy in 6'-position
09/20/2007WO2006084412A9 Method for purifying noroxymorphone compounds
09/20/2007US20070219373 Preparation of oxycodone
09/19/2007EP1834634A2 Pharmaceutical multiple-unit composition
09/13/2007WO2007103105A2 Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
09/13/2007CA2644095A1 Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds
09/12/2007CN101033228A Method of preparing 14-hydroxy-7,8-dihydromorphone
09/11/2007US7267968 Microbial n-and o-demethylation of a thebaine derivative
09/07/2007WO2007098860A1 New morphine compounds for pharmaceutical compositions
09/05/2007EP1829878A1 New morphine derivatives and pharmaceutical compositions containing the same
09/04/2007US7265226 Interact with opoid receptors; decreasing metabolic rates of the phenolic piperidines by amidation, imidation, or forming a formamide, a hydroxyamidine or a thioamide; analgesics, anticonvulsants, antitussive agents; diarrhea, drug addiction
08/2007
08/30/2007US20070203165 Compounds and methods for lowering the abuse potential and extending the duration of action of a drug
08/29/2007CN101027307A Preparation of opiate analgesics by reductive alkylation
08/23/2007US20070197572 Oxycodone polymorphs
08/22/2007EP1820505A1 Analgesic
08/16/2007US20070191595 6-Monoacetyl morphine compounds, derivatized at either the C-3, the C-6, or the nor position with a carrier or label such as keyhole limpet hemocyanin, bovine thyroglobulin, bovine serum albumin, or aminodextran; useful for detecting drugs of abuse in biological samples
08/07/2007CA2270955C Pharmaceutical composition containing morphinan derivative for treating drug dependence
08/02/2007US20070179169 Oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone
08/01/2007CN101010006A Herbicide combinations comprising special ketoenoles
07/2007
07/26/2007WO2007062184A3 Processes for reducing contaminating michael acceptor levels in oxycodone and other compositions
07/25/2007EP1810973A1 6-monoacetylmorphine derivatives useful in immunoassay
07/25/2007CN1328280C Tetrandrine and tetrandrine compound, synthesis and uses thereof
07/19/2007WO2007081506A1 The use of oripavine as a starting material for buprenorphine
07/19/2007CA2636271A1 The use of oripavine as a starting material for buprenorphine
07/18/2007EP1807433A1 Method for separation and purification of hydrocodone by preparative chromatography
07/17/2007CA2389235C Controlled release hydrocodone formulations
07/11/2007EP1204414B1 Use of morphinan derivates as medicines
07/10/2007CA2427815C Controlled release hydrocodone formulations
07/04/2007EP1803724A1 N-substituted hydromorphones and the use thereof
06/2007
06/28/2007WO2007072749A1 Antitussive agent
06/20/2007CN1984912A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors
06/19/2007US7232829 Analgesics; anticonvulsants; hypotensive agents; brain damage; antiarrhythmia agents; opioid receptors
06/16/2007CA2571093A1 6-monoacetylmorphine derivatives useful in immunoassay
06/13/2007EP1794165A1 Preparation of opiate analgesics by reductive alkylation
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 24